메뉴 건너뛰기




Volumn 32, Issue 3, 2011, Pages 556.e13-556.e23

Amyloid precursor protein (APP) processing genes and cerebrospinal fluid APP cleavage product levels in Alzheimer's disease

(16)  Bekris, L M a,b   Galloway, N M a   Millard, S a   Lockhart, D a   Li, G c   Galasko, D R d   Farlow, M R e   Clark, C M f   Quinn, J F g,h   Kaye, J A g   Schellenberg, G D k   Leverenz, J B a,c,j   Seubert, P i   Tsuang, D W a,c   Peskind, E R a,c   Yu, C E a,b  


Author keywords

ADAM10; Alzheimer's; APH1B; APP; BACE1; BACE2; Cerebrospinal fluid; NCSTN; PEN2; PSEN1; PSEN2

Indexed keywords

ADAM10 ENDOPEPTIDASE; AMYLOID BETA PROTEIN[1-42]; AMYLOID PRECURSOR PROTEIN; AMYLOID PRECURSOR PROTEIN ALPHA; AMYLOID PRECURSOR PROTEIN BETA; ANTERIOR PHARYNX DEFECTIVE 1 PROTEIN; APOLIPOPROTEIN E4; BETA SECRETASE 1; BETA SECRETASE 2; NICASTRIN; PRESENILIN 1; PRESENILIN 2; UNCLASSIFIED DRUG;

EID: 79952902413     PISSN: 01974580     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neurobiolaging.2010.10.020     Document Type: Article
Times cited : (41)

References (74)
  • 2
    • 0142250857 scopus 로고    scopus 로고
    • Functional gamma-secretase complex assembly in Golgi/trans-Golgi network: interactions among presenilin, nicastrin, Aph1, Pen-2, and gamma-secretase substrates
    • Baulac S., Lavoie M.J., Kimberly W.T., Strahle J., Wolfe M.S., Selkoe D.J., Xia W. Functional gamma-secretase complex assembly in Golgi/trans-Golgi network: interactions among presenilin, nicastrin, Aph1, Pen-2, and gamma-secretase substrates. Neurobiol. Dis 2003, 14:194-204.
    • (2003) Neurobiol. Dis , vol.14 , pp. 194-204
    • Baulac, S.1    Lavoie, M.J.2    Kimberly, W.T.3    Strahle, J.4    Wolfe, M.S.5    Selkoe, D.J.6    Xia, W.7
  • 4
    • 77952889956 scopus 로고    scopus 로고
    • CREB's control of intrinsic and synaptic plasticity: implications for CREB-dependent memory models
    • Benito E., Barco A. CREB's control of intrinsic and synaptic plasticity: implications for CREB-dependent memory models. Trends Neurosci 2010, 33:230-240.
    • (2010) Trends Neurosci , vol.33 , pp. 230-240
    • Benito, E.1    Barco, A.2
  • 7
    • 42149110867 scopus 로고    scopus 로고
    • Part-time alpha-secretases: the functional biology of ADAM 9, 10 and 17
    • Deuss M., Reiss K., Hartmann D. Part-time alpha-secretases: the functional biology of ADAM 9, 10 and 17. Curr. Alzheimer Res 2008, 5:187-201.
    • (2008) Curr. Alzheimer Res , vol.5 , pp. 187-201
    • Deuss, M.1    Reiss, K.2    Hartmann, D.3
  • 8
    • 46749142660 scopus 로고    scopus 로고
    • Do CSF total tau, phosphorylated tau, and beta-amyloid 42 help to predict progression of mild cognitive impairment to Alzheimer's disease?. A systematic review and meta-analysis of the literature
    • Diniz B.S., Pinto Junior J.A., Forlenza O.V. Do CSF total tau, phosphorylated tau, and beta-amyloid 42 help to predict progression of mild cognitive impairment to Alzheimer's disease?. A systematic review and meta-analysis of the literature. World J. Biol. Psychiatry 2008, 9:172-182.
    • (2008) World J. Biol. Psychiatry , vol.9 , pp. 172-182
    • Diniz, B.S.1    Pinto Junior, J.A.2    Forlenza, O.V.3
  • 10
    • 70349783752 scopus 로고    scopus 로고
    • Influence of ADAM10 on prion protein processing and scrapie infectiosity in vivo
    • Endres K., Mitteregger G., Kojro E., Kretzschmar H., Fahrenholz F. Influence of ADAM10 on prion protein processing and scrapie infectiosity in vivo. Neurobiol. Dis 2009, 36:233-241.
    • (2009) Neurobiol. Dis , vol.36 , pp. 233-241
    • Endres, K.1    Mitteregger, G.2    Kojro, E.3    Kretzschmar, H.4    Fahrenholz, F.5
  • 12
    • 44949221768 scopus 로고    scopus 로고
    • Increased CSF-BACE 1 activity is associated with ApoE-epsilon 4 genotype in subjects with mild cognitive impairment and Alzheimer's disease
    • Ewers M., Zhong Z., Burger K., Wallin A., Blennow K., Teipel S.J., Shen Y., Hampel H. Increased CSF-BACE 1 activity is associated with ApoE-epsilon 4 genotype in subjects with mild cognitive impairment and Alzheimer's disease. Brain 2008, 131:1252-1258.
    • (2008) Brain , vol.131 , pp. 1252-1258
    • Ewers, M.1    Zhong, Z.2    Burger, K.3    Wallin, A.4    Blennow, K.5    Teipel, S.J.6    Shen, Y.7    Hampel, H.8
  • 14
    • 0026744058 scopus 로고
    • Low cerebrospinal fluid concentrations of soluble amyloid beta-protein precursor in hereditary Alzheimer's disease
    • Farlow M., Ghetti B., Benson M.D., Farrow J.S., Van Nostrand W.E., Wagner S.L. Low cerebrospinal fluid concentrations of soluble amyloid beta-protein precursor in hereditary Alzheimer's disease. Lancet 1992, 340:453-454.
    • (1992) Lancet , vol.340 , pp. 453-454
    • Farlow, M.1    Ghetti, B.2    Benson, M.D.3    Farrow, J.S.4    Van Nostrand, W.E.5    Wagner, S.L.6
  • 18
    • 84880187571 scopus 로고    scopus 로고
    • Tau protein, the paired helical filament and Alzheimer's disease
    • Goedert M., Klug A., Crowther R.A. Tau protein, the paired helical filament and Alzheimer's disease. J. Alzheimers Dis 2006, 9:195-207.
    • (2006) J. Alzheimers Dis , vol.9 , pp. 195-207
    • Goedert, M.1    Klug, A.2    Crowther, R.A.3
  • 19
    • 33750705653 scopus 로고    scopus 로고
    • A century of Alzheimer's disease
    • Goedert M., Spillantini M.G. A century of Alzheimer's disease. Science 2006, 314:777-781.
    • (2006) Science , vol.314 , pp. 777-781
    • Goedert, M.1    Spillantini, M.G.2
  • 20
    • 85047694516 scopus 로고    scopus 로고
    • Persistent improvement in synaptic and cognitive functions in an Alzheimer mouse model after rolipram treatment
    • Gong B., Vitolo O.V., Trinchese F., Liu S., Shelanski M., Arancio O. Persistent improvement in synaptic and cognitive functions in an Alzheimer mouse model after rolipram treatment. J. Clin. Invest 2004, 114:1624-1634.
    • (2004) J. Clin. Invest , vol.114 , pp. 1624-1634
    • Gong, B.1    Vitolo, O.V.2    Trinchese, F.3    Liu, S.4    Shelanski, M.5    Arancio, O.6
  • 24
    • 0002294347 scopus 로고
    • A simple sequential rejective multiple test procedure
    • Holm S. A simple sequential rejective multiple test procedure. Scandinavian Journal of Statistics 1979, 6:65-70.
    • (1979) Scandinavian Journal of Statistics , vol.6 , pp. 65-70
    • Holm, S.1
  • 31
    • 0030007964 scopus 로고    scopus 로고
    • Sequence of deposition of heterogeneous amyloid beta-peptides and APO E in Down syndrome: implications for initial events in amyloid plaque formation
    • Lemere C.A., Blusztajn J.K., Yamaguchi H., Wisniewski T., Saido T.C., Selkoe D.J. Sequence of deposition of heterogeneous amyloid beta-peptides and APO E in Down syndrome: implications for initial events in amyloid plaque formation. Neurobiol. Dis 1996, 3:16-32.
    • (1996) Neurobiol. Dis , vol.3 , pp. 16-32
    • Lemere, C.A.1    Blusztajn, J.K.2    Yamaguchi, H.3    Wisniewski, T.4    Saido, T.C.5    Selkoe, D.J.6
  • 32
    • 37549040895 scopus 로고    scopus 로고
    • Promoter polymorphisms which modulate APP expression may increase susceptibility to Alzheimer's disease
    • Jia and Jia
    • Lv H. Promoter polymorphisms which modulate APP expression may increase susceptibility to Alzheimer's disease. Neurobiology of Aging 2008, 29:194-202. Jia and Jia.
    • (2008) Neurobiology of Aging , vol.29 , pp. 194-202
    • Lv, H.1
  • 34
    • 0021271971 scopus 로고
    • Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease
    • Mckhann G., Drachman D., Folstein M., Katzman R., Price D., Stadlan E.M. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 1984, 34:939-944.
    • (1984) Neurology , vol.34 , pp. 939-944
    • Mckhann, G.1    Drachman, D.2    Folstein, M.3    Katzman, R.4    Price, D.5    Stadlan, E.M.6
  • 39
    • 0025302430 scopus 로고
    • Soluble derivatives of the beta amyloid protein precursor in cerebrospinal fluid: alterations in normal aging and in Alzheimer's disease
    • Palmert M.R., Usiak M., Mayeux R., Raskind M., Tourtellotte W.W., Younkin S.G. Soluble derivatives of the beta amyloid protein precursor in cerebrospinal fluid: alterations in normal aging and in Alzheimer's disease. Neurology 1990, 40:1028-1034.
    • (1990) Neurology , vol.40 , pp. 1028-1034
    • Palmert, M.R.1    Usiak, M.2    Mayeux, R.3    Raskind, M.4    Tourtellotte, W.W.5    Younkin, S.G.6
  • 40
  • 44
    • 42149165496 scopus 로고    scopus 로고
    • A closer look at alpha-secretase
    • Postina R. A closer look at alpha-secretase. Curr. Alzheimer Res 2008, 5:179-186.
    • (2008) Curr. Alzheimer Res , vol.5 , pp. 179-186
    • Postina, R.1
  • 47
    • 24644483112 scopus 로고    scopus 로고
    • Genomic structure and functional characterization of the human ADAM10 promoter
    • Prinzen C., Muller U., Endres K., Fahrenholz F., Postina R. Genomic structure and functional characterization of the human ADAM10 promoter. FASEB J. 2005, 19:1522-1524.
    • (2005) FASEB J. , vol.19 , pp. 1522-1524
    • Prinzen, C.1    Muller, U.2    Endres, K.3    Fahrenholz, F.4    Postina, R.5
  • 48
    • 2542454942 scopus 로고    scopus 로고
    • Requirement of PEN-2 for stabilization of the presenilin N-/C-terminal fragment heterodimer within the gamma-secretase complex
    • Prokop S., Shirotani K., Edbauer D., Haass C., Steiner H. Requirement of PEN-2 for stabilization of the presenilin N-/C-terminal fragment heterodimer within the gamma-secretase complex. J. Biol. Chem 2004, 279:23255-23261.
    • (2004) J. Biol. Chem , vol.279 , pp. 23255-23261
    • Prokop, S.1    Shirotani, K.2    Edbauer, D.3    Haass, C.4    Steiner, H.5
  • 49
    • 58449133739 scopus 로고    scopus 로고
    • S100A7, a novel Alzheimer's disease biomarker with non-amyloidogenic alpha-secretase activity acts via selective promotion of ADAM-10
    • Qin W., Ho L., Wang J., Peskind E., Pasinetti G.M. S100A7, a novel Alzheimer's disease biomarker with non-amyloidogenic alpha-secretase activity acts via selective promotion of ADAM-10. PLoS ONE 2009, 4:e4183.
    • (2009) PLoS ONE , vol.4
    • Qin, W.1    Ho, L.2    Wang, J.3    Peskind, E.4    Pasinetti, G.M.5
  • 51
    • 77249122985 scopus 로고    scopus 로고
    • Molecular network analysis suggests aberrant CREB-mediated gene regulation in the Alzheimer disease hippocampus
    • Satoh J., Tabunoki H., Arima K. Molecular network analysis suggests aberrant CREB-mediated gene regulation in the Alzheimer disease hippocampus. Dis. Markers 2009, 27:239-252.
    • (2009) Dis. Markers , vol.27 , pp. 239-252
    • Satoh, J.1    Tabunoki, H.2    Arima, K.3
  • 53
    • 60349122253 scopus 로고    scopus 로고
    • Effect of a dominant-negative form of ADAM10 in a mouse model of Alzheimer's disease
    • Schroeder A., Fahrenholz F., Schmitt U. Effect of a dominant-negative form of ADAM10 in a mouse model of Alzheimer's disease. J. Alzheimers Dis 2009, 16:309-314.
    • (2009) J. Alzheimers Dis , vol.16 , pp. 309-314
    • Schroeder, A.1    Fahrenholz, F.2    Schmitt, U.3
  • 56
    • 4744375540 scopus 로고    scopus 로고
    • Identification of distinct gamma-secretase complexes with different APH-1 variants
    • Shirotani K., Edbauer D., Prokop S., Haass C., Steiner H. Identification of distinct gamma-secretase complexes with different APH-1 variants. J. Biol. Chem 2004, 279:41340-41345.
    • (2004) J. Biol. Chem , vol.279 , pp. 41340-41345
    • Shirotani, K.1    Edbauer, D.2    Prokop, S.3    Haass, C.4    Steiner, H.5
  • 58
    • 34250847115 scopus 로고    scopus 로고
    • The proteins BACE1 and BACE2 and beta-secretase activity in normal and Alzheimer's disease brain
    • Stockley J.H., O'Neill C. The proteins BACE1 and BACE2 and beta-secretase activity in normal and Alzheimer's disease brain. Biochem. Soc. Trans 2007, 35:574-576.
    • (2007) Biochem. Soc. Trans , vol.35 , pp. 574-576
    • Stockley, J.H.1    O'Neill, C.2
  • 62
    • 62449262536 scopus 로고    scopus 로고
    • Cerebrospinal fluid {beta}-amyloid 42 and tau proteins as biomarkers of Alzheimer-type pathologic changes in the brain
    • Tapiola T., Alafuzoff I., Herukka S.K., Parkkinen L., Hartikainen P., Soininen H., Pirttila T. Cerebrospinal fluid {beta}-amyloid 42 and tau proteins as biomarkers of Alzheimer-type pathologic changes in the brain. Arch. Neurol 2009, 66:382-389.
    • (2009) Arch. Neurol , vol.66 , pp. 382-389
    • Tapiola, T.1    Alafuzoff, I.2    Herukka, S.K.3    Parkkinen, L.4    Hartikainen, P.5    Soininen, H.6    Pirttila, T.7
  • 65
    • 67649359888 scopus 로고    scopus 로고
    • Up-regulation of the alpha-secretase ADAM10 by retinoic acid receptors and acitretin
    • Tippmann F., Hundt J., Schneider A., Endres K., Fahrenholz F. Up-regulation of the alpha-secretase ADAM10 by retinoic acid receptors and acitretin. FASEB J. 2009, 23:1643-1654.
    • (2009) FASEB J. , vol.23 , pp. 1643-1654
    • Tippmann, F.1    Hundt, J.2    Schneider, A.3    Endres, K.4    Fahrenholz, F.5
  • 66
    • 0042634362 scopus 로고    scopus 로고
    • Roles of amyloid precursor protein and its fragments in regulating neural activity, plasticity and memory
    • Turner P.R., O'Connor K., Tate W.P., Abraham W.C. Roles of amyloid precursor protein and its fragments in regulating neural activity, plasticity and memory. Prog. Neurobiol 2003, 70:1-32.
    • (2003) Prog. Neurobiol , vol.70 , pp. 1-32
    • Turner, P.R.1    O'Connor, K.2    Tate, W.P.3    Abraham, W.C.4
  • 70
    • 29644432040 scopus 로고    scopus 로고
    • Pen-2 is incorporated into the gamma-secretase complex through binding to transmembrane domain 4 of presenilin 1
    • Watanabe N., Tomita T., Sato C., Kitamura T., Morohashi Y., Iwatsubo T. Pen-2 is incorporated into the gamma-secretase complex through binding to transmembrane domain 4 of presenilin 1. J. Biol. Chem 2005, 280:41967-41975.
    • (2005) J. Biol. Chem , vol.280 , pp. 41967-41975
    • Watanabe, N.1    Tomita, T.2    Sato, C.3    Kitamura, T.4    Morohashi, Y.5    Iwatsubo, T.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.